....... or Root who is gonna scalp your money that you invested a few years ago you dumb schmuck with terrible timing .....
Interesting theory, here's mine - they authorize a r/s at the meeting in early June. They announce a financing a couple days later to finance the Phase II / III. The shares get hit by about 15% and they get shorted another 15%-20% so the end result is a $3.00 share taking into effect a 1:10 split. Then we burn cash and wait for first readout next Spring at which point they try and partner. If no partner they finance again.... Just my pinion of course, actually evet can differ materially, do your own DD and consult the SEC filings and listen to the quarterly conference calls (doh!!! my bad)
Problem was Turpin messed up bad and he's gone. Some would argue he's under Dodd's watch and ultimately Dodd is responsible. So far Dodd is making the right moves after giving Turpin the plank. Company is moving in the right direction.
.... and they had new interest as well? Are we going into a bidding war?
Either renegotiate ESTROGEL for better terms or jettison it fast. Bring on a new 3rd commercial product. Sign some MACRILEN and ZOPTREX International deals. Drive APIFINY and SAIZEN through the roof. Cut more cost and increase communication. We have a winner here.